Eli Lilly Lymphoma Drug, Enzastaurin, Fails In Late-Stage Trial
Category: WELLNESS
The drug, enzastaurin, was being tested in lymphoma patients who were at high risk of relapse following chemotherapy treatment
By Reuters, Reuters, 2013-05-10